Neuron function relies on and instructs the development and precise organization of neurovascular units that in turn support circuit activity. However, our understanding of the molecular cues that regulate this relationship remains sparse. Using a highthroughput screening pipeline, we recently identified several new regulators of vascular patterning. Among these was the potassium channel tetramerization domain-containing protein 7 (KCTD7). Mutations in KCTD7 are associated with progressive myoclonic epilepsy, but how KCTD7 regulates neural development and function remains poorly understood. To begin to identify such mechanisms, we focus on mouse retina, a tractable part of the central nervous system that contains precisely ordered neuron subtypes supported by a trilaminar vascular network. We find that deletion of Kctd7 results in defective patterning of the adult retina vascular network, resulting in increased branching, vessel length, and lacunarity. These alterations reflect early and specific defects in vessel development, as emergence of the superficial and deep vascular layers were delayed. These defects are likely due to a role for Kctd7 in inner retina M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 2 neurons. Kctd7 it is absent from vessels but present in neurons in the inner retina, and its deletion resulted in a corresponding increase in the number of bipolar cells in development and increased vessel branching in adults. These alterations were accompanied by retinal function deficits. Together, these data suggest that neuronal Kctd7 drives growth and patterning of the vasculature and suggest that neurovascular interactions may participate in the pathogenesis of KCTD7-related human diseases.
Introduction
The central nervous system (CNS) is one of the most energetically demanding parts of the body, and it relies on vasculature to appropriately meet the metabolic demand of neuron signaling, circuit function, and ultimately behavior. Correspondingly, a large number of neural diseases are associated with vascular defects, including those that are the most common and the most costly (e.g. Alzheimer's disease and Parkinson's disease, reviewed in Kisler et al., 2017; Sweeny et al., 2018 ). Yet, we know relatively little about the spectrum of molecules that can instruct neurovascular interactions or mediate pathogenic or protective outcomes in disease. In part, this is because the CNS is made up of thousands of types of neurons, each of which have unique properties, signaling modalities, and energetic demands. Since these cell types and circuits are only beginning to be mapped, it has remained difficult to decode the contribution of neuron subtypes and molecules to vascular outcomes.
To overcome these challenges, we focus here on the murine retina. Retina neurons are ordered in precise layers termed lamina that form an organized array of distinct neuron subsets (approximately ~100 types, Macosko et al., 2015) In mouse, as in human, retinal neurons are supported by a trilaminar intraretinal vascular network (Stahl et al., 2010; Usui et al., 2015a) . The vascular layers consist of the superficial plexus, which interdigitates the GCL, the intermediate plexus, which ascends into the IPL, and the deep plexus which interleaves the OPL (Stahl et al., 2010) . These vessel layers function as neurovascular units comprised of endothelial cells, mural cells, astrocytes, and neurons (Rhodes and Simons, 2007; Ladecola, 2017) .
In turn, each layer has a characteristic location, branching pattern, and complexity.
Because the pattern of these networks is stereotyped and influenced by local neuron interactions (Usui et al., 2015b; Selvam et al., 2017; Paredes et al., 2018) , the retina vascular layers provide an ideal system to dissect neurovascular interactions.
Given these features, we recently established a pipeline for using mouse retina to identify new regulators of neurons, vasculature, and their interactions (Albrecht et al., 2018) . This screen implicated several novel genes in retinal vasculature organization, including the potassium channel tetramerization domain-containing protein 7 (Kctd7).
This gene is of particular interest for two reasons. First, it is implicated in progressive myoclonic epilepsy, a rare but serious human neural disease characterized by the presence of abnormal muscle contraction and seizures (Azizieh et al., 2011; Kousi et 4 al., 2012; Staropoli et al., 2012; Van Bogaert, 2016) . Since mouse models for this disease have not been available, its pathogenesis is not well understood. Second, KCTD7 is part of a large family of related proteins that regulate a diverse array of functions ranging from potassium channel tetramerization to ubiquitination (Kreusch et al. 1998; Krek, W, 2003; Genschik et al., 2013; Liu et al., 2013) . But whether and how such proteins can influence the vasculature remains unknown.
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Here, we show that Kctd7 is a regulator of vasculature organization and development in specific regions of the retina. Loss of Kctd7 resulted in increased vessel branching and vessel area in the deep and intermediate vessel layers in adults. Further, emergence of the superficial and deep vasculature layer was delayed, and deep layer
Kctd7
-/-vessels were less complex early in development. These alterations likely reflect a neuron-specific role for Kctd7 as its expression appears restricted to neurons.
Correspondingly, alterations to the deep vascular layer were accompanied by a Kctd7-dependent increase in bipolar cell numbers in the first postnatal week. These retinal defects were accompanied by declines in retinal function. These studies are the first to implicate Kctd7 in vasculature regulation and suggest that neuron driven vascular changes could influence KCTD7-related human neurological diseases.
Materials and Methods

Mouse Strains
The Kctd7-null mutant (Kctd7 -/-) was provided by the International Mouse
Phenotyping Consortium and was generated on a C57BL/6NJ background. This background contains the rd8 mutation, but this does not impact retinal organization
within the time frame of this analysis (Albrecht et al., 2018) . Wildtype C57BL/6NJ controls were used for all studies, and pups were age-matched within 0. compound (VWR), frozen in methyl butane on dry ice, sectioned at 20 µm, and then mounted on Superfrost slides. Slides were incubated in blocking solution (3% normal donkey serum and 0.3% Triton X-100 [vol/vol] in PBS) for 1 hour, followed by incubation with primary antibodies overnight at 4°C and secondary antibodies for 1 hour at room temperature. For whole mount staining of the vasculature, the retina was removed from the optic cup following fixation and then incubated in blocking solution (10% normal donkey serum and 0.5% Triton X-100 [vol/vol] in PBS) followed by primary antibody labeling at 4°C for 7 days and secondary antibody labeling at 4°C for an additional 7 days. For vascular cross-section staining, fixed retinas were removed from the optic cup and embedded in 5% low melting point agarose. A vibratome (Leica VT1200) was used to generate 100 µm sections, which were then incubated in blocking solution (10%
normal donkey serum and 0.5% Triton X-100 [vol/vol] in PBS) followed by primary antibody labeling at 4°C for 3 days and secondary antibody labeling at 4°C for an additional 3 days. All samples were mounted in Vectashield (Vectorlabs). Images were acquired on an Olympus FluoView FV1200 confocal microscope and processed using
Fiji. Images were acquired with the following specifications: antibody cross section, 211 µm x 211 µm; whole mount, 635 µm x 635 µm; vessel cross section, 211 µm x 211 µm;
and in situ, 211µm x 211 µm.
Histological quantification.
For quantification, images were collected from 5 to 10 animals per group with at least 3 image stacks per animal. For vasculature quantification, retinas were harvested and processed for whole mount staining using an antibody to CD31. Images were acquired at equivalent retinal eccentricities from the optic nerve head and processed using Fiji. The number of branch points were quantified in merged images from 20-50 consecutive optical sections in order to separately visualize the superficial, intermediate, and deep layers. To quantify the total vessel area and mean lacunarity, we employed automated segmentation and reconstruction using Angiotool v0.6a. (Zudaire et al., 2011) . To determine the relative retinal area occupied by vessel layers over development, retinas were whole mounted, and the area covered by the vasculature was computed relative to the total retina area. To examine cones, bipolars, amacrines, horizontal cells, and retinal ganglion cells and quantify their numbers, we used antibodies that mark each cell type specifically (Supplemental Table 1 ). Two image stacks were acquired at equivalent retinal eccentricities from the optic nerve head per
animal. The total number of soma for each cell type was quantified in a standardized 211µm x 211µm optical sections from 5-10 non-successive optical sections per image stack.
In situ hybridization.
In situ hybridization was performed by the RNA In Situ Hybridization Core at BCM using an automated robotic platform as previously described (Yaylaoglu et al., 2005) . We prepared digoxigenin (DIG)-labeled riboprobes using reverse-transcribed mouse cDNA as a template that was generated from RNA harvested from mouse brain at E15 and P7. First strand cDNA synthesis was performed using the Superscript IV First-Strant Synthesis System (Invitrogen). Polymerase chain reaction (PCR) primers were used to generate cDNA fragments corresponding to the desired riboprobes for Cspg4 and Kctd7 (Supplemental Table 2 ). DIG-labeled riboprobes were synthesized using a DIG RNA labeling kit (Roche) and stored in hybridization buffer at a concentration of 100 ng/µl at stored at −20°C.
For in situ hybridization retinas were cryoprotected in 30% sucrose, frozen in OCT (VWR), cryosectioned 20µm, and mounted on Superfrost Plus slides (VWR). Sections were fixed and acetylated before the hybridization procedure, which was performed on a high-throughput platform. The slides were developed using tyramide labeled with Cy3 directly (TSA-Plus system; Perkin-Elmer Life Sciences) for 15 min and then stained with 4',6-diamidino-2-phenylindole (DAPI) before mounting in Prolong Diamond (Invitrogen).
We performed ERG on adult 16 week-old animals controls as previously described (Albrecht et al., 2018) . In brief, mice (n = 7 mutants and 8 wildtype) were dark adapted overnight and anesthetized with 1.5% isoflurane at an oxygen flow rate of 1.0 L/min.
Mice were placed on a heated platform and phenylephrine hydrochloride and tropicamide was used to topically dilate the pupil. Electroretinograms were monitored The ground electrode was subcutaneously placed into the forehead, and a reference electrode was placed into the hip.
Statistical Analysis.
Statistical analyses on neuron numbers and ERG results were performed using an unpaired, two-tailed Student's t test. Vascular branch number, total area, lacunarity, and quantification data were analyzed using a two-way ANOVA using the animal as the unit of analysis and allowing for unequal variance. No statistical analysis was conducted to pre-determine sample sizes. Randomization and blinding were not employed.
Statistical differences were evaluated using Graphpad Prism 7 software. P<0.05 was considered statistically significant.
Results
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Kctd7 is required for vascular organization
To examine the role of Kctd7 in retina vascular organization, we obtained Kctd7- 
Kctd7
-/-mice displayed normal development of the superficial layer at P3 (16% versus 17% of the retinal area covered by vessels in wildtype and Kctd7 -/-mice respectively,
Fig. 2B-D).
However, as the superficial layer grew, defects in Kctd7 -/-mice emerged.
While wildtype animals displayed a superficial plexus that covered the majority of the retina at P8 (92%), Kctd7 -/-mice showed a small but significant reduction in superficial layer growth, averaging 84% coverage at this time point (P<0.01, Fig. 2D ). In parallel, branching of the superficial plexus was increased in Kctd7 -/-mice relative to wildtype
controls at P8 (501 ± 129 versus 350 ± 52 branch points/mm 2 respectively, P<0.01, Fig.   2E ).
Since the development of the superficial layer at P8 coincides with the emergence of the deep vasculature layer, we examined whether these events impacted deep layer formation. To begin this analysis, we built on previous work to describe the time course in which the deep layer emerges and then covers the retina surface. In wildtype mice, the deep layer was not present at P3, but it could be readily detected at P8 when it occupied 53% of the retinal surface ( Fig. 3A-C) . In contrast, emergence and extension of the deep vessel layer was reduced in Kctd7 -/-mice, resulting in a 43%
reduction in coverage at this time point relative to wildtype mice (P<0.001, Fig.3A-C) . In addition, regions that were occupied by the deep vascular plexus showed a dramatically reduced vessel density, resulting in an 84% reduction in deep layer vessel branching in
Kctd7
-/-mice (P<0.001; Fig.3B, D) . The alterations in vascular development persisted until P12, when the intermediate layer began to emerge (Fig. 3B-D) . Together, these data indicate that Kctd7 is required for proper temporal emergence and patterning of the intraretinal vasculature and particularly impacts the deep vascular layer.
Kctd7 may function in bipolar neurons to drive vasculature patterning
In the retina, each vascular layer can function as an individual neurovascular unit, such that changes to the vasculature can either induce or reflect local metabolic or neuronal defects (Paredes et al., 2018) . We reasoned that while alterations to all layers of the vasculature might indicate that Kctd7 functions in the vasculature itself, the layerspecific defects we observed in Kctd7 -/-mice might indicate that Kctd7 could play a local
or neuron-specific role. To begin to examine this, we performed in situ labeling over development to localize Kctd7 expression. To examine key stages of this process, we first used probes against Cspg4, also known as NG2 (a pericyte marker, Ozerdem et al., 2001) , to visualize the vasculature (Fig. 4) . As expected, Cspg4 was detected in early development where it localized to thin bands. As development progressed, Cspg4 labeling became more pronounced in the OPL, IPL, and GCL, consistent with the location of the deep, intermediate, and superficial vascular plexus. This pattern differed significantly from that of Kctd7. Unlike Cspg4, Kctd7 was present in fate committed inner retina neurons as by P3 (Fig. 4A) . From P8 to P12, Kctd7 was present throughout the nuclear layers, with the highest levels of expression in the inner nuclear layer ( Fig. 
4B-C). This pattern persisted into adulthood (Fig. 4D). Consistent with these results,
Kctd7 expression has been documented in retina neurons previously by both in situ and RNA-seq studies (Serial Analysis of Gene Expression, SAGE, https://cgap.nci.nih.gov/SAGE/mSEM Blackshaw et al., 2001; Blackshaw et al., 2004; Shekhar et al.,2016) .
Because Kctd7 was expressed predominately in inner retina neurons, we next asked whether it may impact the organization or numbers of retina neuron subsets. To test this, we performed immunohistochemical assays to quantify each major retina neuron type at P8 when vascular defects emerge. We grouped the neuron markers based on the neurovascular unit that each cell type interfaces with. The superficial layer interacts with neurons in the GCL, which primarily includes RGCs (Sapieha et al., 2008; Edwards et al., 2012) 5A ). To examine these populations, we stained for markers that label each of these neuron types specifically (Supplemental Table 1 ). The numbers of RGCs, photoreceptors, amacrines, and horizontal cells were unchanged in Kctd7 -/-mice ( Fig.   5B-C) . Notably, however, bipolar cell development was altered. At P8 Kctd7 -/-mice displayed an 21% increase in the total number of bipolar cells relative to wildtype controls (1.47 ± 0.0.3 versus 1.23 ± 0.14 cells/500µm 2 , respectively, P<0.05, Fig. 5D-E) .
This increase appeared to be specific for the first postnatal week, as by P12 bipolar cell Fig. 5G-F) . These data suggest that Kctd7 alters bipolar cell numbers early in development and that these differences are normalized over time by a compensatory increase in bipolar cell death.
Kctd7 is required for visual function.
To determine the impact of Kctd7-mediated alterations on visual function, we (Fig. 6B-C) .
Under light adapted conditions, the a-wave also trended lower (Fig. 6D) , and significant reductions were observed in the b-wave (33% reduction at a flash intensity of 3 cd*s/m 2 , P=0.012, and a 36% reduction at a flash intensity of 10 cd*s/m 2 , P=0.03, Fig. 6E ).
Collectively, these results suggest that Kctd7-mediated changes in the retina disrupt visual function.
Discussion
The molecular programs that coordinate neuron development with vascular development have been challenging to resolve due to the heterogeneity and complexity of neurons and vessels in the brain. Here, we leverage the murine retina to examine the function of the progressive myoclonic epilepsy-associated gene KCTD7. et al. 1968; Blanks et al., 1974; Rich et al, 1997) . Third, synaptic proteins like VGLUT1 become present, and synapses themselves begin to be active (Sherry et al., 2003) . Thus, we speculate that during development Kctd7-dependent changes in neural activity may impact the integration of bipolar cells into developing synapses. Since retina vasculature can be highly structurally responsive to retina neural alterations (Sapieha et al., 2008; Fukushima et al., 2011; Edwards et al., 2012; Usui et al., 2015b) , this imbalance may in turn influence not only bipolar cell development but also delay vessel emergence and complexity. How Whole mount retinas from wildtype and Kctd7 -/-animals were stained for CD31 at P3, P8, and P12. In wildtype animals, the deep layer has not emerged at P3 but becomes visible by P8 and forms a complex and patterned plexus. In Kctd7 -/-animals, the deep layer is only sparsely present at P8 (A, scale bars = 250µm) and displays discontinuous vessel coverage and a reduction in growth across the retina (B, scale bars = 100µm). • Kctd7 is required for normal retinal vascular organization and retinal function in adults.
C-D. The defects in
• Deletion of Kctd7 disrupts the emergence of the superficial and deep vessel layers.
• Kctd7 may impact vascular patterning through influencing neurons as it is expressed in and regulates bipolar cells.
• Kctd7 driven neurovascular interactions may participate in the pathogenesis of KCTD7-related human diseases.
Lay Summary
Neuron function requires an organized vasculature to maintain brain health and prevent disease, but many neurovasculature regulatory genes remain unknown. Alevy et al.
identify the progressive myoclonic epilepsy-associated gene Kctd7 as a key regulator of vascular development and retinal function. They further show that Kctd7 regulation of vessel patterning likely occurs downstream of its role in regulating the development or activity of specific neuron types. These data suggest that KCTD7-regulated neurovascular interactions may participate in the pathogenesis of associated human diseases.
